Status:
COMPLETED
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
Lead Sponsor:
Abbott
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The TRAIL study was conducted to examine the effects of escalating doses of an ACE inhibitor, trandolapril, on lowering blood pressure in Stage 1-2 hypertensive patients.
Eligibility Criteria
Inclusion
- Stage 1 or 2 Hypertension
Exclusion
- Uncontrolled diabetes
- Subject has a hypersensitivity to ACE inhibitor
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00233532
Start Date
March 1 2004
Last Update
July 22 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.